Customization: | Available |
---|---|
CAS No.: | Customs, Customs |
Formula: | Customs, Customs |
Still deciding? Get samples of US$ 120/G
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Umeclidinium bromide exhibits high selectivity for the M3 muscarinic receptor subtype, which is mainly present in the smooth muscles of the airways. By blocking these receptors, it reduces bronchoconstriction and mucus production, providing relief in COPD symptoms and improving lung function.
ApplicationUmeclidinium bromide is primarily used in the treatment of COPD, including chronic bronchitis and emphysema. It is commonly administered through inhalation as a maintenance therapy to prevent symptoms and exacerbations in patients with persistent airflow limitation. Umeclidinium bromide, along with other bronchodilators, helps manage COPD symptoms, improves exercise tolerance, and enhances patients' quality of life by reducing breathlessness, coughing, and wheezing.